BRPI0520014A2 - emulsões oftálmicas estáveis de óleo-em-água com hialuronato de sódio para alìvio de olho seco - Google Patents

emulsões oftálmicas estáveis de óleo-em-água com hialuronato de sódio para alìvio de olho seco

Info

Publication number
BRPI0520014A2
BRPI0520014A2 BRPI0520014-8A BRPI0520014A BRPI0520014A2 BR PI0520014 A2 BRPI0520014 A2 BR PI0520014A2 BR PI0520014 A BRPI0520014 A BR PI0520014A BR PI0520014 A2 BRPI0520014 A2 BR PI0520014A2
Authority
BR
Brazil
Prior art keywords
dry eye
sodium hyaluronate
eye relief
stable oil
water
Prior art date
Application number
BRPI0520014-8A
Other languages
English (en)
Inventor
Zhi-Jian Yu
Stanley W Huth
Lauren L Crawford
James N Cook
Original Assignee
Advanced Medical Optics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medical Optics Inc filed Critical Advanced Medical Optics Inc
Publication of BRPI0520014A2 publication Critical patent/BRPI0520014A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/141—Biguanides, e.g. chlorhexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/141—Biguanides, e.g. chlorhexidine
    • A61L12/142—Polymeric biguanides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EMULSõES OFTáLMICAS ESTáVEIS DE óLEO-EM-áGUA COM HIALURONATO DE SóDIO PARA ALìVIO DE OLHO SECO. A presente invenção refere-se a emulsões óleo-em-água que contêm um demulcente para o tratamento olho seco, como o hialuronato de sódio. As emulsões óleo-em-água são estáveis e possuem atividade antimicrobiana suficiente para serem utilizadas como soluções de desinfecção de lentes de contato.
BRPI0520014-8A 2005-04-04 2005-09-23 emulsões oftálmicas estáveis de óleo-em-água com hialuronato de sódio para alìvio de olho seco BRPI0520014A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/098,827 US20050196370A1 (en) 2003-03-18 2005-04-04 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
PCT/US2005/034055 WO2006107330A1 (en) 2005-04-04 2005-09-23 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye

Publications (1)

Publication Number Publication Date
BRPI0520014A2 true BRPI0520014A2 (pt) 2009-04-14

Family

ID=35501164

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520014-8A BRPI0520014A2 (pt) 2005-04-04 2005-09-23 emulsões oftálmicas estáveis de óleo-em-água com hialuronato de sódio para alìvio de olho seco

Country Status (8)

Country Link
US (2) US20050196370A1 (pt)
EP (1) EP1868620A1 (pt)
JP (1) JP2008534680A (pt)
CN (1) CN101151038A (pt)
AU (1) AU2005330293A1 (pt)
BR (1) BRPI0520014A2 (pt)
CA (1) CA2605386A1 (pt)
WO (1) WO2006107330A1 (pt)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6702949B2 (en) 1997-10-24 2004-03-09 Microdiffusion, Inc. Diffuser/emulsifier for aquaculture applications
US20110075507A1 (en) * 1997-10-24 2011-03-31 Revalesio Corporation Diffuser/emulsifier
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
US20060251685A1 (en) * 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
SG157374A1 (en) * 2004-11-09 2009-12-29 Abbott Medical Optics Inc Ophthalmic solution
PT1905453E (pt) * 2005-07-13 2012-12-04 Santen Pharmaceutical Co Ltd Composição conservante para utilização oftálmica
CN103120287B (zh) 2005-10-04 2016-01-20 吉米安仕有限责任公司 制造小吃食品的方法及由此制造的产品
MX355043B (es) 2005-10-04 2018-04-02 Jimmyash Llc Productos alimenticios fritos con contenido de grasa reducido.
US9615601B2 (en) 2005-10-04 2017-04-11 Jimmyash Llc Process for the controlled introduction of oil into food products
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US20070087962A1 (en) * 2005-10-17 2007-04-19 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
WO2007070463A2 (en) * 2005-12-12 2007-06-21 Riolan Technologies, Inc. Compositions, methods and kits for removing debris from an ocular area
US8673297B2 (en) 2006-02-28 2014-03-18 Basf Corporation Chlorine dioxide based cleaner/sanitizer
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
US20070264226A1 (en) * 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
US8088300B2 (en) * 2006-06-21 2012-01-03 Basf Corporation Stabilized composition for producing chlorine dioxide
US20080020064A1 (en) * 2006-07-21 2008-01-24 Advanced Vision Research Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
US8609148B2 (en) 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
JP5306214B2 (ja) 2006-10-25 2013-10-02 リバルシオ コーポレイション 混合装置
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
CA2667791A1 (en) * 2006-10-25 2008-05-02 Revalesio Corporation Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
EP2083876A4 (en) 2006-10-25 2012-09-19 Revalesio Corp WOUND CARE AND TREATMENT METHOD
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
JP5850602B2 (ja) * 2006-12-21 2016-02-03 サンテン・エス・エー・エス 眼科用水中油型乳剤を製造する方法
JP5563745B2 (ja) * 2007-04-04 2014-07-30 大正製薬株式会社 点眼剤
EP1985298A1 (en) * 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
US8609634B2 (en) 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US9579341B2 (en) * 2007-05-16 2017-02-28 Johnson & Johnson Consumer Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
JP2009175731A (ja) * 2007-12-28 2009-08-06 Rohto Pharmaceut Co Ltd グリセリンおよびリン酸化合物を含有する亜塩素酸類化合物含有水性組成物
US20110046033A1 (en) * 2008-01-31 2011-02-24 Jinzhong Zhang Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function
US9096819B2 (en) * 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US20090239954A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Phosphate buffered ophthalmic solutions displaying improved efficacy
CA2723215A1 (en) 2008-05-01 2009-11-05 Revalesio Corporation Compositions and methods for treating digestive disorders
HUE024146T2 (en) 2008-05-07 2016-02-29 Univ California Medical filling and enrichment of eye surface lubrication
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
US20100086512A1 (en) * 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
US10117906B2 (en) 2009-01-09 2018-11-06 The Schepens Eye Research Institute, Inc. Methods for reducing corneal nerves damage, corneal lymphangiogenesis or immunity to corneal antigens in dry-eye associated ocular surface diseases by IL-1Ra
US20100233101A1 (en) 2009-02-13 2010-09-16 Micropure, Inc. Composition and method for the oxidative consumption of salivary biomolecules
US20100234319A1 (en) * 2009-03-11 2010-09-16 Abbott Medical Optics Inc. Complex of Polymeric Quaternary Ammonium and Anionic Polymers as a New Antimicrobial Agent for Ophthalmic Compositions
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
WO2010136594A2 (en) * 2009-05-29 2010-12-02 Symatese Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
JP5601805B2 (ja) * 2009-08-24 2014-10-08 キユーピー株式会社 経口用ドライアイ改善剤、ならびに前記経口用ドライアイ改善剤を含む食品組成物および医薬品組成物
US9717703B2 (en) 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
WO2011070612A1 (ja) * 2009-12-08 2011-06-16 株式会社メニコン コンタクトレンズパッケージの製造方法
JP2013523825A (ja) * 2010-04-07 2013-06-17 アラーガン インコーポレイテッド 眼科製剤のための保存剤組成物の組み合わせ
CN104983740A (zh) 2010-05-07 2015-10-21 利发利希奥公司 用于增强生理性能和恢复时间的组合物和方法
JP2013533320A (ja) 2010-08-12 2013-08-22 レバレジオ コーポレイション タウオパチーを治療するための組成物および方法
IT1401922B1 (it) * 2010-09-09 2013-08-28 Ibsa Inst Biochimique Sa Processo per ottenere acido ialuronico a peso molecolare definito
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica
AU2013222801B2 (en) * 2012-02-24 2015-09-17 Bausch & Lomb Incorporated Ophthalmic compositions with alkoxylated natural waxes
KR101211902B1 (ko) * 2012-04-30 2012-12-13 주식회사 휴온스 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
US20140235554A1 (en) * 2013-02-12 2014-08-21 Brian Lawrence Ophthalmic formulation derived from silk protein
FR3002452B1 (fr) * 2013-02-28 2016-02-12 Dermaconcept Jmc Composition dermatologique antimicrobienne topique
US10052313B2 (en) * 2013-08-28 2018-08-21 Presbyopia Therapies, LLC Compositions and methods for the treatment of presbyopia
US11344538B2 (en) * 2013-08-28 2022-05-31 Lenz Therapeutics, Inc. Methods for the treatment of myopia
US11179327B2 (en) * 2013-08-28 2021-11-23 Lenz Therapeutics, Inc. Compositions and methods for the treatment of presbyopia
US10307408B2 (en) * 2013-08-28 2019-06-04 Presbyopia Therapies, LLC Contact lens compositions and methods for the treatment of presbyopia
US10617763B2 (en) * 2013-08-28 2020-04-14 Presbyopia Therapies, LLC Compositions and methods for the treatment of presbyopia
US10959990B2 (en) * 2013-08-28 2021-03-30 Presbyopia Therapies, Inc Compositions and methods for the treatment of presbyopia
WO2015048223A2 (en) * 2013-09-27 2015-04-02 Novartis Ag Compositions and methods for disinfecting and cleaning contact lenses
JP2014028865A (ja) * 2013-11-11 2014-02-13 Santen Sas 眼科用水中油型乳剤を製造する方法
CN103805069B (zh) * 2014-01-27 2016-03-02 欧普康视科技股份有限公司 一种角膜接触镜抛光液及其制备方法
CA2994222C (en) 2014-08-20 2020-09-08 Silk Technologies, Ltd. Fibroin-derived protein composition
TR201819920T4 (tr) 2014-12-12 2019-01-21 Alfa Intes Ind Terapeutica Splendore S R L Kuru göz sendromunun tedavisinde kullanım için oftalmik bileşimler.
MX2017010544A (es) * 2015-02-24 2018-06-18 Univ Illinois Metodos y composiciones para tratar la enfermedad del ojo seco y otros trastornos del ojo.
US20180221278A1 (en) * 2015-02-24 2018-08-09 Ocugen, Inc. Prsustained release opthalmic formuation and methods for using the same
US9877964B2 (en) 2015-02-24 2018-01-30 Ocugen, Inc. Methods and compositions for treating dry eye disease and other eye disorders
US10751337B2 (en) * 2015-02-24 2020-08-25 Ocugen, Inc. Preservative free ocular compositions and methods for using the same for treating dry eye disease and other eye disorders
KR20180014825A (ko) * 2015-06-18 2018-02-09 프레스바이오피아 세라피스, 엘엘씨 눈의 굴절 이상 치료 및 원거리 시력 개선용 조성물 및 방법
KR101635915B1 (ko) * 2016-02-15 2016-07-04 삼천당제약주식회사 사이클로스포린과 히알루론산 또는 이의 염을 포함하는 수용액 형태의 안과용 조성물
GB2560483A (en) * 2016-02-22 2018-09-12 Coopervision Int Holding Co Lp Silicone hydrogel contact lenses having improved lubricity
SG11201808804TA (en) 2016-04-08 2018-11-29 Univ Cornell A method to enhance wound healing using silk-derived protein
US11242367B2 (en) 2016-08-12 2022-02-08 Silk Technologies, Ltd. Silk-derived protein for treating inflammation
CN107789657A (zh) * 2016-08-30 2018-03-13 欧普康视科技股份有限公司 一种硬性接触镜护理液
EP4438749A3 (en) 2016-11-14 2025-01-08 Lilac Solutions, Inc. Lithium extraction with coated ion exchange particles
WO2018212846A1 (en) 2017-05-19 2018-11-22 Ocugen, Inc. Ophthalmic compositions and methods of use
IT201700068170A1 (it) * 2017-06-20 2018-12-20 Iromed Group S R L Composizione disinfettante per uso oftalmico
US10439200B2 (en) 2017-08-02 2019-10-08 Lilac Solutions, Inc. Ion exchange system for lithium extraction
AR112663A1 (es) 2017-08-02 2019-11-27 Lilac Solutions Inc Extracción de litio con perlas porosas de intercambio iónico
CA3020197C (en) 2017-09-01 2024-06-04 Micropure, Inc. Aliphatic anionic compounds and oxidative compounds with improved stability and efficacy for use in pharmaceutical compositions
TWI884130B (zh) 2018-02-21 2025-05-21 瑞士商愛爾康公司 基於脂質的眼用乳劑
KR20200116526A (ko) 2018-02-28 2020-10-12 리락 솔루션즈, 인크. 리튬 추출을 위한 입자 트랩을 가진 이온 교환 반응기
US12337056B2 (en) 2018-05-29 2025-06-24 Mary Kay Inc. Topical compositions and methods
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
RU2692087C1 (ru) * 2018-11-27 2019-06-21 Илья Александрович Марков Глазные гелеобразные капли для лечения острых и хронических воспалительных заболеваний глаз, вызванных вирусными, бактериальными, аллергическими, метаболическими или травматическими факторами
EP3982930A1 (en) 2019-06-11 2022-04-20 SIFI S.p.A. Microemulsion compositions
US11944097B2 (en) 2019-07-01 2024-04-02 Aseptic Health, LLC Antimicrobial composition
MX388336B (es) * 2019-09-06 2025-03-19 Sophia Holdings S A De C V Composicion farmacéutica oftálmica, procesos de preparación y usos de las mismas
US11969454B2 (en) * 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CN111248221A (zh) * 2020-02-13 2020-06-09 上海克琴科技有限公司 一种通过协效物稳定的长效型消毒剂
EP3919047A1 (en) * 2020-06-03 2021-12-08 AZAD Pharma AG Microemulsion for the treatment of dry eye syndrome
CA3178825A1 (en) 2020-06-09 2021-12-16 David Henry SNYDACKER Lithium extraction in the presence of scalants
IT202000027155A1 (it) * 2020-11-12 2022-05-12 Sifi Spa Formulazione a base di poliesametilene biguanide per il trattamento della cheratite da acanthamoeba
IT202000029288A1 (it) * 2020-12-01 2022-06-01 Altergon Sa Sali di microbiocidi biguanidinici con glicosamminoglicani
CN112716886B (zh) * 2020-12-03 2022-07-08 国药集团三益药业（芜湖）有限公司 一种醋酸地塞米松乳膏及其制备方法
WO2022156371A1 (zh) * 2021-01-22 2022-07-28 成都瑞沐生物医药科技有限公司 一种眼用制剂的载体或辅料及其制备方法和应用
CN114788840A (zh) * 2021-01-25 2022-07-26 陆达斌 眼睛及视力保养液
CN112842936A (zh) * 2021-03-15 2021-05-28 傅博 一种眼部清洁液及其制备方法
KR20240014047A (ko) 2021-04-23 2024-01-31 리락 솔루션즈, 인크. 리튬 추출을 위한 이온 교환 장치
WO2023091439A1 (en) 2021-11-17 2023-05-25 Lenz Therapeutics, Inc. Aceclidine derivatives, compositions thereof and methods of use thereof
US11648247B1 (en) 2021-12-16 2023-05-16 Lenz Therapeutics, Inc. Compositions and methods for the treatment of presbyopia
ES2944784B8 (es) * 2021-12-23 2026-04-21 Univ Madrid Complutense Microemulsión oftálmica, procedimiento de obtención y uso dado a la misma
EP4499260A4 (en) 2022-03-28 2026-04-01 Lilac Solutions Inc DEVICES FOR THE EFFICIENT USE OF SORBANTS IN LITHIUM EXTRACTION
AR128953A1 (es) 2022-04-01 2024-06-26 Lilac Solutions Inc Extracción de litio con aditivos químicos
US20240165147A1 (en) * 2022-11-21 2024-05-23 Bausch + Lomb Ireland Limited Methods for Treating Eyetear Film Deficiency
WO2025108987A1 (en) * 2023-11-21 2025-05-30 Bausch + Lomb Ireland Limited Compositions and methods for treating eyetear film deficiency and redeye
US20250281392A1 (en) * 2024-03-08 2025-09-11 Aquestive Therapeutics, Inc. Topical delivery of epinephrine and prodrug compositions
US12414942B1 (en) 2024-03-15 2025-09-16 Lenz Therapeutics Operations, Inc. Compositions, methods, and systems for treating presbyopia

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258063A (en) * 1978-06-23 1981-03-24 Henkel Corporation Self-emulsifying cosmetic base
US4818614A (en) * 1985-07-29 1989-04-04 Shiseido Company Ltd. Modified powder
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
JPH05503527A (ja) * 1990-02-22 1993-06-10 マクノート・ピーティーワイ・リミテッド 人工涙液
AU668509B2 (en) * 1991-04-19 1996-05-09 Affinity Biotech, Inc. Convertible microemulsion formulations
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
PL192080B1 (pl) * 1997-07-29 2006-08-31 Upjohn Co Kompozycja farmaceutyczna zawierająca związek piranonowy
WO1999029316A1 (en) * 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
US6979456B1 (en) * 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
FR2787027B1 (fr) * 1998-12-14 2001-01-12 Oreal Nanoemulsion a base d'esters gras de sucre ou d'ethers gras de sucre et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6506394B1 (en) * 1999-06-30 2003-01-14 Kimberly-Clark Worldwide, Inc. Delivery of a botanical extract to a treated substrate for transfer to skin
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
EP1142566B1 (fr) * 2000-04-07 2003-10-01 Laboratoire Medidom S.A. Formulations ophtalmiques à base de ciclosporine, d'acide hyaluronique et du polysorbate
US20030185878A1 (en) * 2000-06-23 2003-10-02 Tetsuo Hoshino Process for producing phospholipid-containing drug
US7235230B2 (en) * 2001-10-24 2007-06-26 Clariant Finance (Bvi) Limited Leave-on compositions for personal care
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation

Also Published As

Publication number Publication date
CN101151038A (zh) 2008-03-26
US20050196370A1 (en) 2005-09-08
AU2005330293A1 (en) 2006-10-12
JP2008534680A (ja) 2008-08-28
US20070036829A1 (en) 2007-02-15
WO2006107330A1 (en) 2006-10-12
CA2605386A1 (en) 2006-10-12
EP1868620A1 (en) 2007-12-26

Similar Documents

Publication Publication Date Title
BRPI0520014A2 (pt) emulsões oftálmicas estáveis de óleo-em-água com hialuronato de sódio para alìvio de olho seco
SV2009003235A (es) Triazoles biciclicos como moduladores de la proteina cinasa ref. x-18476m
EA200970514A1 (ru) Способ получения текстиля с десенсибилизированными компонентами серебра
BR112015019044A2 (pt) adesivos antimicrobianos tendo proprieda-des aperfeiçoadas
CL2017000498A1 (es) Una formulación de n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforida (galns)(divisional solicitud 219-2013)
PA8840801A1 (es) Derivaos de dioxa-biciclo[3.2.1]octano-2,3,4-triol
AR062046A1 (es) Soluciones oftalmicas
BR112012008677A2 (pt) compostos amino-pirimidina como inibidores de tbkl e/ou ikk epsilon
CR20110043A (es) Mezclas fungicidas que comprenden 1-metilpirazol-4-ilcarboxanilidas sustituidas
BR112012019437A2 (pt) 5-alquinil-pirimidinas
ECSP088152A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
EA201300898A1 (ru) Композиция для окислительного фотоактивируемого омоложения кожи, содержащая гиалуроновую кислоту, глюкозамин или аллантоин
BRPI0909100A2 (pt) Composição de cetorolaco de trometamina para tratar ou prevenir dor ocular
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
NO20084749L (no) Organiske forbindelser og deres anvendelser
CR10137A (es) Agente terapéutico para la diabetes
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
CO6341526A2 (es) Povidona yodada, un preservativo alternativo novedoso para composiciones oftalmologicas
CL2010001620A1 (es) Composicion agricola, del cuidado personal, del cuidado de la casa y de revestimiento que comprende silicona y otro componente adicional; emulsion acuosa y no acuosa que comprende la composicion agricola; y metodo para formular dichas composiciones (div. sol. n° 656-207).
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
SG157374A1 (en) Ophthalmic solution
WO2007124476A3 (en) Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
CR20110660A (es) Mezclas fungicidas
CL2008003372A1 (es) Compuestos derivados de metil-bencimidazol, procedimiento de preparacion, composicion farmaceutica que los contiene y uso en el tratamiento y/o profilaxis de enfermedades afectadas por moduladores de fxr, en particular, dislipidemia, enfermedades de absorcion de colesterol y aterosclerosis, entre otras.
BRPI0408827A (pt) composições oftálmicas preservadas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.